Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Suvorexant for Insomnia in Breast Cancer Survivors
NCT06162663Phase 4Terminated
- Sponsor
- Medical University of South Carolina
- Start
- Sep 2024
- Primary completion
- Jan 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of suvorexant in Insomnia, sponsored by Medical University of South Carolina. Started Sep 2024; status: terminated.
02
Drugs
suvorexant
03
Conditions
Insomnia
Beyond the preview
Go deeper on NCT06162663.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06162663.